Trial intelligence / Profile preview

Bioequivalence of Ketoprofen Lysine Salt Tablets vs Oral Solution

NCT02350296Phase 1Completed

Sponsor
Dompé
Start
Nov 2014
Primary completion
Dec 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of ketoprofen lysine salt in pain (2 arms), sponsored by Dompé. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve from time 0 to last measurable concentration. Started Nov 2014; status: completed.

02

Drugs

ketoprofen lysine salt
03

Conditions

pain

Beyond the preview

Go deeper on NCT02350296.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02350296.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call